6Scheiman JM. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. Gastroenterol Clin North Am, 2009,38:305-314.
7Bytzer P, Dahlerup JF, Eriksen JR, et al. Diagnosis and treatment of Helicobacter pylori infection. Dan ~Med Bull, 2011,58:C4271.
8Hiraishi H, Maeda M, Sasai T, et al. Strategy to manage low dose aspirin-induced gastrointestinal injury. Nippon Rinsho, 2011,69:369-375.
9Goldstein. Who needs prophylaxis of nonsteroidal anti-inflammato- ry drug-induced ulcers and what is optimal prophylaxis? Eur J Gastroenterol Hepatol, 2000,12(Suppl 1):S11-15.
10Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht Ⅲ Consensus Report. Gut, 2007,56:772-781.
